Differential expression of Semaphorin-7A /CD163-positive macrophages in large artery and cardiogenic stroke.
BMC Neurol
; 24(1): 70, 2024 Feb 19.
Article
em En
| MEDLINE
| ID: mdl-38373967
ABSTRACT
BACKGROUND:
Identification of the causes of stroke of undetermined etiology, specifically cardioembolism (CE) and non-CE causes, can inform treatment planning and prognosis prediction. The objective of this study was to analyze the disparities in thrombus composition, particularly Semaphorin-7A (Sema7A) and CD163, between patients diagnosed with large-artery atherosclerosis (LAA) and those with CE, and to investigate their potential association with prognosis.METHODS:
Thrombi were collected from patients who underwent mechanical thrombectomy at two hospitals. The patients were categorized into two groups LAA and CE. We compared the levels of Sema7A and CD163 between these groups and analyzed their relationships with stroke severity, hemorrhagic transformation and prognosis.RESULTS:
The study involved a total of 67 patients. Sema7A expression was found to be significantly higher in the CE group compared to LAA (p < 0.001). Conversely, no statistically significant differences were observed for CD163 between the groups. The presence of Sema7A/CD163 did not show any associations with stroke severity or hemorrhagic transformation (all p > 0.05). However, both Sema7A (OR, 2.017; 95% CI, 1.301-3.518; p = 0.005) and CD163 (OR, 2.283; 95% CI, 1.252-5.724; p = 0.03) were associated with the poor prognosis for stroke, after adjusting for stroke severity.CONCLUSION:
This study highlights that CE thrombi exhibited higher levels of Sema7A expression compared to LAA thrombi. Moreover, we found a positive correlation between Sema7A/CD163 levels and the poor prognosis of patients with acute ischemic stroke.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Acidente Vascular Cerebral
/
Semaforinas
/
Aterosclerose
/
AVC Isquêmico
Limite:
Humans
Idioma:
En
Revista:
BMC Neurol
Ano de publicação:
2024
Tipo de documento:
Article